Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?

doi:10.4240/wjgs.v13.i10.1235

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3190)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

157

WORD

HTML

1474

Figures (1-3)

224

Tables (1-2)

218

Sum=2118

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

389

Download

683

Sum=1072

Oct 27, 2021 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Oct 27, 2021; 13(10): 1235-1244
Published online Oct 27, 2021. doi: 10.4240/wjgs.v13.i10.1235

Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival curves between neoadjuvant chemotherapy and surgery only groups. A: Overall survival; B: Disease-free survival.

Citation: Park JS, Van der Wall H, Kennedy C, Falk GL. Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated? World J Gastrointest Surg 2021; 13(10): 1235-1244
URL: https://www.wjgnet.com/1948-9366/full/v13/i10/1235.htm
DOI: https://dx.doi.org/10.4240/wjgs.v13.i10.1235